FEN1 Cancer Research Results

FEN1, flap endonuclease 1: Click to Expand ⟱
Source:
Type:
FEN1 Flap endonuclease 1 DNA replication and repair Up Structure-specific nuclease involved in Okazaki-fragment maturation, long-patch base-excision repair and replication-fork processing. FEN1 is frequently overexpressed in cancer and can promote tumour-cell proliferation, DNA-damage repair and treatment resistance. Therapeutic inhibition or downregulation increases replication stress and DNA damage, suppresses proliferation and may produce synthetic lethality in homologous-recombination-deficient cancers.


Scientific Papers found: Click to Expand⟱
7037- GA,  Chit,    Gallic acid-loaded chitosan nanoparticles enhance the DNA damage and apoptotic features through inhibiting flap endonuclease-1 in triple-negative breast cancer cells
- in-vitro, BC, MDA-MB-231
DNAdam↑, Apoptosis↑, FEN1↓, selectivity↑, ROS↑, DNAdam↑, PARP1↑, TumCP↓, p‑PI3K↓, Akt↓, cycD1/CCND1↓, BAX↑, Casp3↑,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0)

FEN1↓, 1,  

Redox & Oxidative Stress(tgid=1)

ROS↑, 1,  

Cell Death(tgid=5)

Akt↓, 1,   Apoptosis↑, 1,   BAX↑, 1,   Casp3↑, 1,  

DNA Damage & Repair(tgid=10)

DNAdam↑, 2,   PARP1↑, 1,  

Cell Cycle & Senescence(tgid=11)

cycD1/CCND1↓, 1,  

Proliferation, Differentiation & Cell State(tgid=12)

p‑PI3K↓, 1,  

Migration(tgid=13)

TumCP↓, 1,  

Drug Metabolism & Resistance(tgid=21)

selectivity↑, 1,  
Total Targets: 12

Pathway results for Effect on Normal Cells:


Total Targets: 0

Scientific Paper Hit Count for: FEN1, flap endonuclease 1
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:1567  State#:%  Dir#:1
wNotes=0 sortOrder:rid,rpid

 

Home Page